Automated protein-ligand crystallography for structure-based drug design (Q33253602)

24 July 2017

title

Automated protein-ligand crystallography for structure-based drug design (English)

1 reference

24 July 2017

0 references

0 references

1 reference

Wijnand T M Mooij

1

1 reference

24 July 2017

Michael J Hartshorn

2

1 reference

24 July 2017

Ian J Tickle

3

1 reference

24 July 2017

Andrew J Sharff

4

1 reference

24 July 2017

Marcel L Verdonk

5

1 reference

24 July 2017

Harren Jhoti

6

1 reference

24 July 2017

publication date

1 August 2006

1 reference

24 July 2017

1 reference

24 July 2017

volume

1

1 reference

24 July 2017

issue

8

1 reference

24 July 2017

page(s)

827-838

1 reference

Fragment-based lead discovery using X-ray crystallography.

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

High-throughput protein crystallography and drug discovery.

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Automated crystal mounting and data collection for protein crystallography

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Current state of automated crystallographic data analysis.

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

PHENIX: building new software for automated crystallographic structure determination

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Automated crystallographic system for high-throughput protein structure determination.

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Automated protein model building combined with iterative structure refinement

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

AstexViewer: a visualisation aid for structure-based drug design

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Applications for macromolecular map interpretation: X-AUTOFIT, X-POWERFIT, X-BUILD, X-LIGAND, and X-SOLVATE

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

A new test set for validating predictions of protein-ligand interaction.

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Automatic generation of 3D-atomic coordinates for organic molecules

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation.

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitors.

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

The CCP4 suite: programs for protein crystallography

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

AMoRe: an automated package for molecular replacement

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Optimization of parameters for semiempirical methods I. Method

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Development and validation of a genetic algorithm for flexible docking

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Improved protein-ligand docking using GOLD

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Flexible docking using Tabu search and an empirical estimate of binding affinity.

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

[23] Bayesian statistical viewpoint on structure determination: Basic concepts and examples

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Improved Fourier coefficients for maps using phases from partial structures with errors

1 reference

https://api.crossref.org/works/10.1002/CMDC.200600074

7 January 2021

Molecular Quantum Similarity Measures Tuned 3D QSAR: An Antitumoral Family Validation Study

1 reference

7 December 2024

https://opencitations.net/index/api/v1/citations/10.1021/CI9800108

Identifiers

DOI

10.1002/CMDC.200600074

1 reference

24 July 2017

1 reference